Trial Profile
Pharmacologic Influence of Escitalopram on the Reduction of Fear Acquisition and Triggered Renewal During Fear Conditioning: a Model for the Prevention and Persistence of Learned Fear and Anxiety in Response to Trauma and Stress
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Anxiety; Depression; Post-traumatic stress disorders; Psychological stress
- Focus Therapeutic Use
- 05 Oct 2013 New trial record